A. Cirelli

发表

Increased levels of circulating ICAM-1 in serum and cerebrospinal fluid of patients with active multiple sclerosis. Correlation with TNF-α and blood-brain barrier damage

E. Thompson, M. Sharief, M. Noori, 1993, Journal of Neuroimmunology.

Dual-Energy x-ray absorptiometry in the early diagnosis of body shape changes in patients with HIV infection treated with nucleoside reverse transcriptase inhibitors and naive to protease inhibitors

M. Marini, R. Masciangelo, A. Cirelli, 2001 .

Frequency of development of acute global left ventricular dysfunction in human immunodeficiency virus infection.

S. De Castro, V. Vullo, G. d’Amati, 1994, Journal of the American College of Cardiology.

Adenosine deaminase activity and acquired immunodeficiency syndrome (AIDS).

V. Vullo, C. Mastroianni, S. Delia, 1987, Clinical chemistry.

Tumour necrosis factor-α mediates blood—brain barrier damage in HIV-1 infection of the central nervous system

V. Vullo, E. Thompson, M. Sharief, 1992, Mediators of inflammation.

Free circulating ICAM-1 in serum and cerebrospinal fluid of HIV-1 infected patients correlate with TNF-α and blood-brain barrier damage

E. Thompson, M. Sharief, M. Noori, 1992, Mediators of inflammation.

Heart involvement in AIDS: a prospective study during various stages of the disease.

S. De Castro, V. Vullo, G. d’Amati, 1992, European heart journal.

Clinical and mycological evaluation of fluconazole in the secondary prophylaxis of esophageal candidiasis in AIDS patients

F. Chiodo, D. Greco, L. Minoli, 1994, European Journal of Epidemiology.

Serum selenium concentration and disease progress in patients with HIV infection.

C. De Simone, R. Giordano, M. Ciardi, 1991, Clinical biochemistry.

Cardiolipin on the surface of apoptotic cells as a possible trigger for antiphospholipid antibodies

G. Valesini, A. Pavan, M. Sorice, 2000, Clinical and experimental immunology.

An open-label, prospective, observational study of the incidence of coronary artery disease in patients with HIV infection receiving highly active antiretroviral therapy.

G. Barbarini, A. Cirelli, G. Bárbaro, 2003, Clinical therapeutics.

Body habitus changes, metabolic abnormalities, osteopenia and cardiovascular risk in patients treated for human immunodeficiency virus infection.

M. Marini, R. Masciangelo, A. Cirelli, 2003, Annali italiani di medicina interna : organo ufficiale della Societa italiana di medicina interna.

The pavia consensus statement.

P. Volberding, M. Moroni, R. Bruno, 2003, AIDS.

Cryptococcus neoformans infection in patients with acquired immunodeficiency syndrome: Clinical forms and therapeutic possibilities

A. Cirelli, A. Scasso, A. Paladini, 1993 .

A clinical approach to cryptococcosis treatment in patients with acquired immune deficiency syndrome

S. Catania, M. Ciardi, A. Cirelli, 1991 .

Cryptococcal meningitis and toxoplasma encephalitis in an AIDS patient.

S. Catania, M. Mascellino, A. Cirelli, 1990, Acta neurologica.

Intrathecal synthesis of interleukin-2 and soluble IL-2 receptor in asymptomatic HIV-1 seropositive individuals Correlation with local production of specific IgM and IgG antibodies

E. Thompson, M. Sharief, M. Noori, 1993, Journal of the Neurological Sciences.

[An unusual mechanism of lead poisoning. Presentation of a case].

G. Biolcati, A. Cirelli, A. Macrì, 1989, Recenti progressi in medicina.

HIV infection, vasculitis and immune complexes.

C. Carini, A. Cirelli, I. Mezzaroma, 1987, AIDS.

High cerebrospinal fluid and serum levels of tumor necrosis factor-α in asymptomatic HIV-1 seropositive individuals. Correlation with interleukin-2 and soluble IL-2 receptor

E. Thompson, M. Sharief, M. Ciardi, 1994, Journal of the Neurological Sciences.